Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
Biorepository of healthy subjects after vaccination or infection with common vaccines and community infectious diseases or from healthy control subjects
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 4, 2026
Sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in participants with advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma expressing Claudin18.2
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 16, 2026
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 16, 2026
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate MGL-3196 (Resmetirom) in Patients with MASH Who Have Undergone Liver Transplant for MASH Cirrhosis or Other Etiologies
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 16, 2026
A phase II/III, open-label, international, multi-center, randomized study of AAA817 versus standard of care in the treatment of adult participants with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu PSMA
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 16, 2026
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date:
November 20, 2026
Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies (RENAL AID)
Study Status:
Open to Enrollment
Primary Investigator:
Alan Perlman, M.D.
Date:
March 15, 2016
(CLONEVO): Cell cycLe inhbitiON to target the EVolution of urOthelial cancer
Study Status:
Open to Enrollment
Primary Investigator:
Bishoy Faltas, M.D.
Date:
June 8, 2018
Autosomal Dominant Polycystic Kidney Disease Data Repository
Study Status:
Open to Enrollment
Primary Investigator:
Blumenfeld, Jon M.D.
Date:
April 28, 2016
Fecal Microbiota Transplantation National Registry
Study Status:
Open to Enrollment
Primary Investigator:
Carl V. Crawford, Jr., MD
Date:
August 24, 2018
« first
‹ previous
…
27
28
29
30
31
32
33
(current)
34
35
next ›
last »